Shenzhen YHLO Biotech Co., Ltd.

Equities

688575

CNE100005204

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. Other stock markets 13/02/2026			5-day change	1st Jan Change
13.60 ^CNY	-0.95%		-5.88%	-4.23%

01-07	YHLO Biotech Discloses 'Uncertainty' Stemming From Recent Partnership With Brain-Machine Starlink	MT
12-24	Shenzhen YHLO Biotech Subsidiary Gets Chinese Provincial-Level Approval for Two Diagnostic Kits	MT

Declaration of Voting Results by Shenzhen YHLO Biotech

Published on 05/26/2025 at 12:09 pm BST

S&P Capital IQ

SHENZHEN YHLO BIOTECH CO., LTD.

-0.95%

On May 26, 2025, Shenzhen YHLO Biotech Co Ltd announced that it had held its annual meeting of shareholders on May 26, 2025, and declared the voting results. Accordingly, a proposal submitted by Kunhui Hu regarding proposal on the replacement of independent directors and related special committee members was approved by the shareholders of the Company.

Latest news about Shenzhen YHLO Biotech Co., Ltd.

01-07	YHLO Biotech Discloses 'Uncertainty' Stemming From Recent Partnership With Brain-Machine Starlink	MT
12-24	Shenzhen YHLO Biotech Subsidiary Gets Chinese Provincial-Level Approval for Two Diagnostic Kits	MT
12-16	Shenzhen YHLO Biotech Gets Chinese Provincial Regulator's Approval for Two Autoimmune Disease Testing Kits	MT
11-28	YHLO Biotech Gets Dutch Certification for HIV Kit	MT
11-26	YHLO Biotech Gets Guangdong Registrations for sST2 Test Kit, Microfluidic Analyzer	MT
11-20	Shenzhen YHLO Biotech Gets Guangdong Approval for Immunoassay Analyzer	MT
11-18	Shenzhen YHLO Biotech Gets Guangdong, China Regulatory Approval for Detection Kit	MT
11-07	YHLO Biotech Gets Registration Certificate for Human Chorionic Gonadotropin Kit	MT
29/10/25	Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025	CI
11/09/25	YHLO Biotech's Controlling Shareholder Trims Stake	MT
25/08/25	Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025	CI
18/08/25	Shenzhen YHLO Biotech's shareholders to unload shares	RE
26/05/25	Declaration of Voting Results by Shenzhen YHLO Biotech	CI
17/05/25	Certain A Shares of Shenzhen YHLO Biotech Co., Ltd. are subject to a Lock-Up Agreement Ending on 17-MAY-2025.	CI
15/05/25	Shenzhen YHLO Biotech Receives Shareholder Proposal from Kunhui Hu	CI

Chart Shenzhen YHLO Biotech Co., Ltd.

Duration

Period

688575: Dynamic Chart

Company Profile

Shenzhen YHLO Biotech Co Ltd is a China-based company principally engaged in the research and development, manufacture and sales of in-vitro diagnostic equipment and supporting reagents, as well as the agency sales of some non-self-produced medical device products. The Company's products are applied in autoimmunity, reproductive health, diabetes and infectious disease fields. The Company's main products include in-vitro diagnostic instruments and supporting reagents based on chemiluminescence, immunoblotting, enzyme-linked immunoassay, immunofluorescence chromatography and other methodologies. The Company distributes its products in domestic market and to overseas markets.

Employees

1,678

Sector

Medical Equipment, Supplies & Distribution

Calendar

04-26 - Q1 2026 Earnings Release (Projected)

More about the company